Hera Biotech
Pre-clinicalDevelops non-invasive diagnostic technologies for endometriosis using proprietary molecular imaging platforms.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.3M
About
Develops non-invasive diagnostic technologies for endometriosis using proprietary molecular imaging platforms.
Diagnostics
Funding History
2Total raised:$2.3M
Grant$250KJun 15, 2021
Seed$2MJun 15, 2020